LexaGene Initiates Program to Identify UK and South African COVID Sequences
13 janv. 2021 08h44 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene to Present at Upcoming SNN Network and H.C. Wainwright Bioconnect 2021 Virtual Events
06 janv. 2021 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Starts FDA EUA Study for Point-of-Care COVID-19 Testing
30 déc. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 30, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene to Place MiQLab Systems at Two Leading Specialty and Emergency Veterinary Care Hospitals
17 déc. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Receives Purchase Order for MiQLab from Ethos Discovery
15 déc. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene to Participate at the 13th Annual LD Micro Main Event Conference
09 déc. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Dec. 09, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Places MiQLab System at the University of Pennsylvania’s School of Veterinary Medicine
18 nov. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Receives Purchase Order from a Multinational Biotechnology Company
16 nov. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Announces Results of Annual General Shareholder’s Meeting
13 nov. 2020 17h00 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene to Present at Two Upcoming Investor Conferences
10 nov. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass, Nov. 10, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...